Potential Shift From Quarterly Earnings Traders Eye Possible Timeline Changes Lenovo Shares Surge Over 15 Following Record Earnings and AI Revenue Surge Salesforce CEO Marc Benioff Outlines Turnaround Plan Amid Stock Slump Focus on Products and Buybacks April Jobs Report Preview Modest Payroll Growth Expected to Signal Stable Labor Market Dow Jones Futures Point Higher as Iran Deal Hopes Lift Markets Tesla AI Stocks in Focus Jim Cramer Expresses Positive View on Palo Alto Networks PANW Market Implications DTIL Q1 2026 Earnings EPS Misses Estimates as Gene Editing Pipeline Progress Takes Center Stage RRBI Q1 2026 Earnings Solid EPS Beat Amid Slight Stock Decline Enbridge Q1 2026 Earnings EPS Beats Estimates Amid Broader Market Weakness MCHPP Q1 2026 Earnings Preferred Stock Delivers EPS Surprise Amid Flat Revenue Disclosures CAG Q1 2026 Earnings EPS Miss Weighs on Shares Amid Cost Pressures DMRC Q1 2026 Earnings EPS Surpasses Estimates with 5267 Beat ZOOZW Warrants Surge 5789 High Volatility at 003 Satellos Bioscience MSLE Surges 7 as Biotech Stock Breaks Above Key Support PAR Technology Surges 249 as Shares Test Key Resistance Level Capital One Financial COF Holds Steady Near Resistance as Volume Signals Caution Nuveen Select Maturities Municipal Fund Holds Steady at 935 Flat Trading Reflects Market Indecision Capgemini Outlines Strategic Plan to Capture AI Growth Opportunities Through 2028 Xeris Biopharma XERS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates eBay Inc EBAY Holds Steady Near 115 as Support and Resistance Levels Tighten Paranovus Entertainment Technology Ltd PAVS Q2 2022 Earnings Massive EPS Miss Highlights Severe Operational Challenges SPB Q1 2026 Earnings Earnings Beat Estimates Amidst Solid Operational Execution FTFT Q2 2024 Earnings Net Loss of 009 Per Share as Company Pivots KRRO Q1 2026 Earnings EPS Beat Driven by Expense Management Evolus EOLS Q1 2026 Earnings EPS Surprises Positively Despite Stock Decline MiNK Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Expectations Amid Clinical Progress MRK Q1 2026 Earnings EPS Surprise on a Loss Stock Declines 22